SCHEMBL31349655

SCHEMBL31349655

O=C1CC(n2cnc3cc(OCCN4CCC5(CC4)C(=O)Nc4ccc(C(F)F)nc45)cc(C(F)(F)F)c32)CN1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 2/20 0.34
▸ DRD2 P14416 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31349475 1.00 ABL1 (0.34) ABL1DRD2
SCHEMBL31349653 1.00 ABL1 (0.34) ABL1DRD2
SCHEMBL31349440 0.78 DRD2 (0.30) DRD2
SCHEMBL31349476 0.78 DRD2 (0.30) DRD2
SCHEMBL31349608 0.77 ADCY10 (0.31) DRD2
SCHEMBL31349508 0.77 — —
SCHEMBL31349501 0.77 DRD2 (0.31) DRD2
SCHEMBL25316830 0.76 ADRA2B (0.33) DRD2
SCHEMBL30506752 0.76 ADRA2B (0.33) DRD2
SCHEMBL26023096 0.76 ADRA2B (0.33) DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743078-A2 APOL1 INHIBITORS AND METHODS OF USE Maze Therapeutics, Inc. (US) 2026-05-20 — — EP disclosed
WO-2025015104-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2025-01-16 — — WO disclosed
Send feedback